BioSpace News Archive

Rocket Pharmaceuticals, Inc., a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces upcoming data presentations at the 63rd American Society of Hematology Annual Meeting taking place virtually and in Atlanta, Georgia from December 11-14, 2021.

NextCure, Inc. announced that new data from two research studies will be presented during oral and poster sessions at the 63rd annual American Society of Hematology annual meeting, to be held in Atlanta, Georgia and in a virtual platform on December 11-14, 2021.

Legend Biotech Corporation today announced that 12 company-sponsored studies were accepted for presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. These include two oral presentations and 10 poster presentations.

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress

ALX Oncology Holdings Inc., today announced the Company will be presenting early clinical data from ASPEN-02, its ongoing Phase 1/2 study evaluating evorpacept in combination with azacitidine for the treatment of myelodysplastic syndromes (“MDS”) in a poster presentation at the 63rd American Society

Keros Therapeutics, Inc. today announced that four abstracts will be presented at the 63rd American Society of Hematology (“ASH”) Annual Meeting and Exposition, to be held in person and virtually from December 11 through 14, 2021.

Keros Therapeutics, Inc. today provided a business update and reported financial results for the quarter ended September 30, 2021.

Mereo BioPharma Group plc announced that data from an investigator-sponsored study of alvelestat in patients with Bronchiolitis Obliterans Syndrome following hematopoietic stem cell transplantation will be shared in a poster presentation at the 2021 American Society of Hematology Annual Meeting, being held December 11-14, 2021 in Atlanta, Georgia and virtually.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced a preclinical poster presentation at the American Society of Hematology Annual Meeting to be held December 11-14, 2021, in Atlanta, GA.

Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three and nine months ended September 30, 2021.